Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)

被引：0
|
作者：
Koki Nakanishi
Daisuke Kobayashi
Yoshinari Mochizuki
Kiyoshi Ishigure
Seiji Ito
Hiroshi Kojima
Akiharu Ishiyama
Shinichi Fujitake
Toshio Shikano
Satoshi Morita
Yasuhiro Kodera
机构：
[1] Komaki City Hospital,Department of Surgery
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery
[3] Konan Kosei Hospital,Department of Surgery
[4] Aichi Cancer Center,Department of Gastroenterological Surgery
[5] Aichi Cancer Center Hospital,Department of Surgery
[6] Okazaki City Hospital,Department of Surgery
[7] Nishio Municipal Hospital,Department of Surgery
[8] Yokkaichi Municipal Hospital,Department of Surgery
[9] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Gastric cancer; S-1; Paclitaxel; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：557 / 565
页数：8
相关论文
共 50 条
  • [41] A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer
    Michiya Kobayashi
    Akira Tsuburaya
    Naoki Nagata
    Yumi Miyashita
    Koji Oba
    Junichi Sakamoto
    Gastric Cancer, 2006, 9 (2) : 114 - 119
  • [42] Phase II study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial.
    Aizawa, Masaki
    Ishigami, Hironori
    Yabusaki, Hiroshi
    Nashimoto, Atsushi
    Imamoto, Haruhiko
    Imano, Motohiro
    Yamashita, Hiroharu
    Kishi, Kentaro
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Fujiwara, Yoshiyuki
    Hidemura, Akio
    Tamura, Shigeyuki
    Fukushima, Ryoji
    Yamaguchi, Hironori
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase Ⅱ clinical trial
    Xiaoying Zhao
    Zhiyu Chen
    Xiaowei Zhang
    Xiaodong Zhu
    Wen Zhang
    Lixin Qiu
    Chenchen Wang
    Mingzhu Huang
    Zhe Zhang
    Wenhua Li
    Lei Yang
    Weijian Guo
    Cancer Biology & Medicine, 2023, 20 (09) : 682 - 688
  • [44] Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase Ⅱ clinical trial
    Xiaoying Zhao
    Zhiyu Chen
    Xiaowei Zhang
    Xiaodong Zhu
    Wen Zhang
    Lixin Qiu
    Chenchen Wang
    Mingzhu Huang
    Zhe Zhang
    Wenhua Li
    Lei Yang
    Weijian Guo
    Cancer Biology & Medicine, 2023, (09) : 682 - 688
  • [45] A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer
    Peng, Ying-Feng
    Imano, Motohiro
    Itoh, Tatsuki
    Satoh, Takao
    Chiba, Yasutaka
    Imamoto, Haruhiko
    Tsubaki, Masahiro
    Nishida, Shozo
    Yasuda, Takushi
    Furukawa, Hiroshi
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (08) : 1041 - 1046
  • [46] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
    Koizumi, Wasaburo
    Narahara, Hiroyuki
    Hara, Takuo
    Takagane, Akinori
    Akiya, Toshikazu
    Takagi, Masakazu
    Miyashita, Kosei
    Nishizaki, Takashi
    Kobayashi, Osamu
    Takiyama, Wataru
    Toh, Yasushi
    Nagaie, Takashi
    Takagi, Seiichi
    Yamamura, Yoshitaka
    Yanaoka, Kimihiko
    Orita, Hiroyuki
    Takeuchi, Masahiro
    LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
  • [47] S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis
    Kitayama, J.
    Ishigami, H.
    Yamaguchi, H.
    Yamashita, H.
    Emoto, S.
    Kaisaki, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 264 - 264
  • [48] Retrospective analysis for S-1 and second-line chemotherapy for stage IV gastric cancer
    Shitara, K
    Mizuno, Y
    Hirata, N
    Yabu, K
    Wada, R
    Kusanagi, H
    Kanou, N
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 265 - 269
  • [49] A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report
    Rino, Yasushi
    Yukawa, Norio
    Murakami, Hitoshi
    Wada, Nobuyuki
    Yamada, Roppei
    Hayashi, Tsutomu
    Sato, Tsutomu
    Ohshima, Takashi
    Masuda, Munetaka
    Imada, Toshio
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 1 - 10
  • [50] A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
    Akihiro Nakajo
    Shuichi Hokita
    Sumiya Ishigami
    Futoshi Miyazono
    Tadaaki Etoh
    Masahiro Hamanoue
    Shigeho Maenohara
    Toshimitsu Iwashita
    Hideaki Komatsu
    Kiyoharu Satoh
    Kuniaki Aridome
    Satoshi Morita
    Shoji Natsugoe
    Hiroya Takiuchi
    Shyuji Nakano
    Yoshihiko Maehara
    Junichi Sakamoto
    Takashi Aikou
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1103 - 1109
12345